Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 13, 2018

DrugPatentWatch Database Preview

Rempex Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for REMPEX PHARMS, and when can generic versions of REMPEX PHARMS drugs launch?

REMPEX PHARMS has two approved drugs.

There are four US patents protecting REMPEX PHARMS drugs.

Summary for Rempex Pharms

US Patents:	4
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for Rempex Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rempex Pharms	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	9,278,105	➤ Try a Free Trial				➤ Try a Free Trial
Rempex Pharms	VABOMERE	meropenem; vaborbactam	POWDER;INTRAVENOUS	209776-001	Aug 29, 2017		RX	Yes	Yes	8,680,136	➤ Try a Free Trial	Y	Y		➤ Try a Free Trial
Rempex Pharms	VABOMERE	meropenem; vaborbactam	POWDER;INTRAVENOUS	209776-001	Aug 29, 2017		RX	Yes	Yes	9,694,025	➤ Try a Free Trial				➤ Try a Free Trial
Rempex Pharms	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	9,084,802	➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for Rempex Pharms Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
European Patent Office	2568987	➤ Try a Free Trial
European Patent Office	3135289	➤ Try a Free Trial
Chile	2012003168	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2012021455	➤ Try a Free Trial
Japan	2013535502	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Rempex Pharms

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte

Chubb

Johnson and Johnson

Cipla

Harvard Business School

Covington

Daiichi Sankyo

Citi

QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.